テボゲン・バイオ・ホールディングスのニュース一覧

Press Release: Tevogen Bio CEO Dr. Ryan Saadi Expresses Gratitude for Prestigious ROI-NJ Recognition, Highlighting Company's Novel Business Model as Key to Sustainable Success Through Patient Affordability

Dow Jones05:43

Tevogen Bio Leverages Microsoft Partnership To Deliver Machine Learning Based Target Identification To Address HPV, Advancing TVGN 920

Benzinga11/05 22:29

12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga11/05 00:40

EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In October 2024 — Where Do Tesla, Nvidia, Apple, DJT Stock Rank?

Benzinga11/05 00:05

Tevogen Bio Expands On Microsoft Partnership To Integrate Machine Learning And AI Into Preclinical Processes, Accelerating Drug Development And Reducing Costs; Says "Current Timeline For Drug Development Is 10-12 Years And Costs ~$1B-$3B. Approach Has...

Benzinga10/31 22:56

Tevogen Bio Reports That The Co Has Regained Nasdaq Listing Compliance

Benzinga10/30 03:37

Alpha Capital Appointed as Exclusive Financial Advisor to CD8 Technology to Secure Funding Up To $50 Million

GlobeNewswire10/30 02:38

Tevogen Bio Signs Letter Of Intent With CD8 Technology To Build Up To A $50M R&D And Manufacturing Facility; No Impact On Shareholder Equity

Benzinga10/30 00:45

Philips Posts Weak Earnings, Joins Clear Channel Outdoor And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Benzinga10/28 20:07

Why LENZ Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

Benzinga10/28 18:32

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Benzinga10/24 20:07

Sector Update: Health Care Stocks Softer Late Afternoon

MT Newswires10/24 03:46

Tevogen Bio Shares Are Soaring Wednesday: What's Going On?

Benzinga10/24 00:41

Tevogen Bio Shares Jump After Tevogen AI Joins Microsoft for Startups

MT Newswires10/23 22:32

Tevogen Bio Specialty Care Announces Its Top-Line Revenue Forecast For Its Specialty Care Pipeline, Projecting Nearly $1B In Revenue In Its Launch Year And A Cumulative 5-Year Estimate Of Between $18B-$22B

Benzinga10/22 04:01

Have Tevogen Bio Holdings Insiders Been Selling Stock?

Simply Wall St10/20 20:59

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga10/18 20:09

Sector Update: Health Care Stocks Decline Late Afternoon

MT Newswires10/18 03:57

Why Is Small-Cap Tevogen Bio Stock Rocketing Higher On Thursday?

Benzinga10/17 23:57

Tevogen Bio Shares Pop After Positive Guidance for Pipeline Cancer Treatments

WSJ10/17 22:48